Gsa Capital Partners LLP Care Dx, Inc. Transaction History

Gsa Capital Partners LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$7.96 - $12.37 $6,073 - $9,438	-763 Reduced 4.17%	17,529 $185,000
Q4 2023 Feb 16, 2024	SELL	$4.9 - $12.86 $233,837 - $613,704	-47,722 Reduced 72.29%	18,292 $219,000
Q3 2023 Nov 15, 2023	BUY	$7.0 - $11.26 $145,124 - $233,442	20,732 Added 45.78%	66,014 $462,000
Q2 2023 Aug 14, 2023	SELL	$7.61 - $9.46 $995,228 - $1.24 Million	-130,779 Reduced 74.28%	45,282 $384,000
Q1 2023 May 12, 2023	BUY	$8.83 - $17.61 $1.55 Million - $3.1 Million	176,061 New	176,061 $1.61 Million
Q2 2020 Aug 11, 2020	SELL	$18.95 - $35.43 $219,516 - $410,421	-11,584 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$13.94 - $28.25 $51,104 - $103,564	-3,666 Reduced 24.04%	11,584 $253,000
Q4 2019 Feb 12, 2020	BUY	$19.24 - $28.41 $59,374 - $87,673	3,086 Added 25.37%	15,250 $329,000
Q3 2019 Nov 12, 2019	BUY	$20.03 - $40.08 $243,644 - $487,533	12,164 New	12,164 $275,000

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.